Diversified Background Equals Strong Operations Experience
Few leaders have the breadth and depth of experience in so many areas and industries:
Tom has spent his career challenging himself across various disciplines, occupations, sectors and industries. He has developed a unique portfolio of experiences in retail, wholesale, manufacturing, distribution, sales, marketing, design, development, financing, acquisition, turnaround and liquidity.
What do others say?
…amazing creativity and vision in advising winning business strategies…
…his advice can definitely help entrepreneurs avoid mistakes and accelerate success…
…able to size up complicated business, legal, financial and technological issues quickly and take the steps necessary to turn them around for a positive result…
…an insightful and authoritative voice in business leadership …
To learn more check out the Experience tab.
Tom Was a panelist at the Oregon Bioscience Association annual conference: An Industry inflection Point.
The Annual conference highlighted Oregon's increasing national role as a hub for biotechnology and bio science research and development. Oregon has long been a strong regional center of life science activity. The momentum and international attention of the $1 Billion OHSU Knight Cancer Challenge has created a “transformative moment” that will dramatically impact bioscience in the state–potentially enhancing commercialization opportunities, increasing resources available for research activity and elevating the visibility of all stakeholders working to solidify Oregon’s growing reputation as a hub for advanced medical research and commercialization.
Tom joined a number of industry experts including: William Goldstein, Ph.D. Director of Lawrence Livermore Nationa Labs, Jeffrey Trent, Ph.D., President and Research Director, Translational Genomics Research Inst., Thomas Fogarty, M.D., Chair/Dir./Founder, Fogarty Institute for Innovation, Ted Goldstein, Ph.D., Center for Biomolecular Science and Engineering, Univ. of CA at Santa Cruz, Jill Hagenkord, M.D., FCAP, Chief Medical Officer, 23andMe and Raymond DuBois, M.D., Executive Director, BioDesign Institute ASU.
Tom and Jill Rissi, Ph.D., Assistant Professor, Portland State University led the Breakout Session II: Innovation in Redefining Healthcare. They discussed that while the debate over the Affordable Care Act continues, Tom and Dr. Rissi showed how the US could best allocate resources, improve access, quality and affordability, and provide appropriate oversight accountability and responsibility. Mr. Loker presented an original and innovative vision of what the current form of America’s “non-‐system” of health care might evolve toward. He stated that he believe that, if we are not already at an inflection point, we soon may be and perhaps should be. His vision of a truly “patient-‐centric” realignment of the activities, roles, and responsibilities seemed necessary to the attendees. In fact many remarked aftehr the presentation they felf the plan was practical, desirable and essential.
The conclusion of the attendees was that research innovation and successful entrepreneurial initiative all depend, ultimately, on adoption and implementation by the providers of America’s health care services. The business, professional and regulatory environment that providers face must undergo further evolution,. This remains a subject of vital interest to Oregon’s Life Science community.
New WhitePaper Available 2/25/2014
We have evolved a belief that we have a system for the delivery of healthcare but, it’s not a system at all. It is a collection of self-predatory practices and methods that promulgate massive increases in costs, erosion of effective checks and balances and exponential unintended consequences.
Click here to view a draft of the whitepaper outlining a pragmatic and effective solution to address the fundamental problems that have plagued our health system and are the reason that no prior "fixes" have actually worked.
Tom Was a panelist at ACG San Francisco 12/10/2013
Audios & Videos
The Joe Show on KGMI Talk 790
Joe talks health care history and reform with Thomas Loker, author of "The History and Evolution of Healthcare in America." . (radio)
WCLO brings you the breaking news as the Supreme Court upholds the Affordable Care Act. What does this mean for Americans? Author Tom Loker probes these concepts and other possibilities for sustainable healthcare in his latest book, The History and Evolution of Healthcare in America. (radio)
I-Universe interview with author Tom Loker on his new book, the History and Evolution of Healthcare in America. (podcast)
Tom in the news
Tom's latest article spurs controversy
Why the Middle Class is Still Getting Crushed: Let's look back!
Tom starts his latest artice with the statement, "It is now crystal clear that the middle class are being destroyed. Politician's explanations are based on pure biased rhetoric. The real reason is much simpler. It is the mechanics of how we are trying to fix the economy." Tom continues to describe how the Affordable Care Act, and many other government attempts to help the country, have had a disasterous effect on the middle class; mostly due to the mechanics of how the soultions have been applied. Apparently, he struck a nerve as this has rapidly become one of the top articles on his blog. If you have not read it, perhaps you should. Visit Tom's Blog to find out more.
Tom Loker, businessman & author, and Jill Rissi, Ph.D. assistant professor, portland state university, present innovation in redefining healthcare at the oregon biosciences association annual conference in Portland.
The presentation was a stimulating discussion of how to stop debating the Affordible Care Act, Obamacare, and how to fix our healthcare system.
The debate over the ACA continues: how should America best allocate resources, improve access, quality and affordability, and provide appropriate oversight accountability and responsibility? Mr. Loker and Dr. Rissi presented an original and innovative vision of what the current form of America's 'non-system' of healthcare might evolve toward. In their vision, a truly "patient-centric" realignment of the activities, roles and responsibilities were not only feasable, but they presented good evidence it is already evolving in the needed direction and the concepts are garnering significant support.
This well attended breakout session provided tremendous benefit to all that attended and sparked some very interesting after session conversations! Overall, it was regarded as a great presentation by the attendees. Visit http://healthreform2dot0.org/ to find out more about the ideas and concepts.
Venture-Med is an exclusive membership organization of accredited investors who want to be introduced to innovative healthcare startups and related investment opportunities.
We are one of the newest angel investment groups in Silicon Valley and we offer our members a screening process to find the best innovative new companies seeking seed funding and mentorship. Our focus is on healthcare and we provide the entrepreneur the expertise to guide and successfully fund. We provide them with representation for syndication with other angel investment groups. This creates a win for the investor and the entrepreneur.
"Tom brings tremendous experience in healthcare and health policy in this new and emerging world of ObamaCare," said Jose Bolanos, M.D., Founder of Venture-Med, "We are very happy to have him accept the role of Senior Advisor."
"I agreed to join Jose, and Venture-Med, because I feel they are developing a new and value based group that will truly help healthcare entrepreneurs, not simply find access to capital, but will help lower the failure rate of startups by more tightly integrating the network access to needed answers and resources in a cost effective and timely manner! I believe this is necessary for Angle investors to be successful in this new healthcare paradigm."
Author and healthcare executive Thomas Loker appeared on the Huffington Post Live segment with Alyona Minkoviski on a panel discussing the rising prevelence of resistant bacteria. Tom discussed the historical perspective and the evolutionaly conundrum we face in treating diseases.
July 2, 2012
Now that we have all heard the decision by the Supreme Court on the Patient Protection and Affordable Care Act (Obamacare), perhaps it is time for some reflection. I know as I read the decision Thursday morning, while I was waiting in the queue preparing for a radio interview on the issue, I felt both vindicated in my initial analysis, but also left wanting and inadequate for not seeing the sideways tax justification for its declared constitutionality. . .